MD Anderson and Nexo Therapeutics partner to advance new cancer therapies against previously undruggable targets
The University of Texas MD Anderson Cancer Center and Nexo Therapeutics today announced a multi-year strategic collaboration that aligns the innovative technology and capabilities of each organization at the earliest stages of drug discovery and development to rapidly advance impactful new cancer therapies against previously undruggable targets.
Source: news-medical.net